Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.
source https://www.sciencedaily.com/releases/2021/08/210806104354.htm
Saturday, 7 August 2021
Related Posts
New clinical risk management tools are needed to prevent COVID-19 deaths, say experts
Why boiling droplets can race across hot oily surfaces
For trees, carbs are key to surviving insect defoliation, study finds
Crop insurance and unintended consequences
Navigating the corn maze: Researchers develop technique to map out 'light switches' of maize genome
Cancer patients use less marijuana than general public, study finds
0 comments: